Pacific Biosciences (PACB) Files $150M Mixed Shelf
Get Alerts PACB Hot Sheet
Join SI Premium – FREE
Pacific Biosciences of California, Inc. (Nasdaq: PACB), filed a registration with the U.S. Securities and Exchange Commission to sell, from time to ime, up to $150 million of Common stock, Preferred stock, Depositary Shares, Warrants, Debt securities, Units, or any combination thereof.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Singularity Future Technology closes $5M registered direct offering
- Aveanna Healthcare prices secondary offering at $11.75 per share
- Werewolf Therapeutics to merge with Ambros in $150M private placement
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share